InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Rubin Jonathan. Officer active across 1 company, notably Supernus Pharmaceuticals, INC.. Cumulatively, 13 reports have been logged. History available since 16 February 2023. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Rubin Jonathan is a declarant linked to Supernus Pharmaceuticals, INC. (XNAS), where he holds the role of SVP, Chief Medical Officer. He has 11 filings in total, and across the 11 sampled filings the most frequent transaction nature is Attribution, with buy and sell amounts at EUR 0; the sampled period runs from 2023-02-21 to 2026-02-26.